To determine whether we could replicate the beneficial effect of TRF on tumor growth using a more aggressive triple-negative breast cancer cell line (ER/PR/HER2 negative), we injected obese OVX mice with E0771 cells (Supplementary Fig. 5a). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.